RP

Ramana Pachikura

Active Director Director DIN 07318070
DIN 07318070 First appointment Dec 2015 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramana Pachikura

Data last updated:

Ramana Pachikura is a Director at Pendurthi Pharmaceuticals Private Limited (since 2015). The company operates in Business Services.

DIN 07318070
Primary Designation Director
Industry Business Services
First Appointment 08 Dec 2015
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Dec 20152015Active

Directorship timeline

Open interactive timeline →
Pendurthi Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ramana Pachikura

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramana Pachikura

Ramana Pachikura currently holds 1 directorship: Pendurthi Pharmaceuticals Private Limited (Director, since 08 Dec 2015).

Ramana Pachikura was first appointed on 08 Dec 2015 as Director at Pendurthi Pharmaceuticals Private Limited.

The current boards of Ramana Pachikura's companies include Bhaskara Rao Gandipadala (Pendurthi Pharmaceuticals Private Limited), Murali Gandipadala (Pendurthi Pharmaceuticals Private Limited), Satyaganapathi Rao Gunturu (Pendurthi Pharmaceuticals Private Limited), Sundar Sekhar Babu Racherla (Pendurthi Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available